Cytocompatibility of PLA/Nano-HA composites for interface fixation

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Polylactic acid (PLA) composite materials are used in bone fixation.
• Nano-hydroxyapatite (Nano-HA) enhances biomechanical properties.
• Biocompatibility and cytotoxicity data are crucial for clinical application.

Purpose of the Study:

• To evaluate the biocompatibility and cytotoxicity of a 20% Nano-HA/PLA composite bone substitute.
• To provide reference data for potential clinical use of this novel biomaterial.

Main Methods:

• Prepared a 20% Nano-HA/PLA composite bone substitute material and its extract.
• Co-cultured rabbit bone marrow mesenchymal stem cells (rBMSCs) with the extract.
• Assessed cell morphology, viability (MTT assay), and relative growth at 3, 5, and 7 days.

Main Results:

• rBMSCs exhibited normal morphology and spindle-shaped adherent growth in the experimental group.
• Relative cell growth was high (95.3% at 3 days, 96.8% at 5 days, 97.6% at 7 days).
• Cytotoxicity was within the safe range, meeting national standards, with no significant difference from the negative control.

Conclusions:

• The 20% Nano-HA/PLA composite demonstrates good cell compatibility.
• The material's cytotoxicity is within acceptable limits for medical use.
• This biomaterial shows promise for orthopedic applications.